Document
IPR2016-01132, No. 1084-133 Exhibit - Exhibit 1084 Lacrisert FDA Label (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01132, No. 1084-133 Exhibit - Exhibit 1084 Lacrisert FDA Label (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1097-146 Exhibit - Exhibit 1097 Adler AllAboutVision Dry Eye (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01132, No. 1097-146 Exhibit - Exhibit 1097 Adler AllAboutVision Dry Eye (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1057-106 Exhibit - Exhibit 1057 Glenn (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01132, No. 1057-106 Exhibit - Exhibit 1057 Glenn (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1106-155 Exhibit - Exhibit 1106 Allergan Q4 2007 Earnings Call (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01132, No. 1106-155 Exhibit - Exhibit 1106 Allergan Q4 2007 Earnings Call (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1076-125 Exhibit - Exhibit 1076 Xiidra (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01132, No. 1076-125 Exhibit - Exhibit 1076 Xiidra (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-00569, No. 1020-19 Exhibit - Exhibit 1020 Murphy (P.T.A.B. Jan. 6, 2017)
Cite Document
IPR2017-00569, No. 1020-19 Exhibit - Exhibit 1020 Murphy (P.T.A.B. Jan. 6, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1046-95 Exhibit - Exhibit 1046 Niederkorn et al (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01132, No. 1046-95 Exhibit - Exhibit 1046 Niederkorn et al (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1038-92 Exhibit - REDACTED Exhibit 1038 Attar Deposition Transcript (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2016-01132, No. 1038-92 Exhibit - REDACTED Exhibit 1038 Attar Deposition Transcript (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1152 Exhibit - EX1152 AAM White Paper Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01132, No. 1152 Exhibit - EX1152 AAM White Paper Renting Tribal Immunity to Evade IPR Review of Pharmaceutical Patents (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01132, No. 2114 Exhibit - Michelle Stephenson, The Latest Uses for Restatis, Review of Opthalmology, Dec 30, 2005 (P.T.A.B. Dec. 15, 2017)
Cite Document
IPR2016-01132, No. 2114 Exhibit - Michelle Stephenson, The Latest Uses for Restatis, Review of Opthalmology, Dec 30, 2005 (P.T.A.B. Dec. 15, 2017)
+ More Snippets
Document
IPR2016-01132, No. 2111 Exhibit - Ex 2111 Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restaysis (P.T.A.B. Oct. 20, 2017)
Cite Document
IPR2016-01132, No. 2111 Exhibit - Ex 2111 Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restaysis (P.T.A.B. Oct. 20, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1148 Exhibit - EX1148 Fox Business (P.T.A.B. Oct. 13, 2017)
Cite Document
IPR2016-01132, No. 1148 Exhibit - EX1148 Fox Business (P.T.A.B. Oct. 13, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1009 Exhibit - Exhibit 1009 US 5,578,586 to Glonek et al (P.T.A.B. Jun. 3, 2016)
Cite Document
IPR2016-01132, No. 1009 Exhibit - Exhibit 1009 US 5,578,586 to Glonek et al (P.T.A.B. Jun. 3, 2016)
+ More Snippets
Document
IPR2016-01132, No. 2108 Exhibit - Ex 2108 PTABs Death Squad Label Not Totally Off Base, Chief Says Law360 (P.T.A.B. Oct. 20, 2017)
Cite Document
IPR2016-01132, No. 2108 Exhibit - Ex 2108 PTABs Death Squad Label Not Totally Off Base, Chief Says Law360 (P.T.A.B. Oct. 20, 2017)
+ More Snippets
Document
IPR2016-01132, No. 1006 Exhibit - Exhibit 1006 US 5,474,979 to Ding et al (P.T.A.B. Jun. 3, 2016)
Cite Document
IPR2016-01132, No. 1006 Exhibit - Exhibit 1006 US 5,474,979 to Ding et al (P.T.A.B. Jun. 3, 2016)
+ More Snippets